Thyroidectomy is the definitive therapeutic intervention for a wide spectrum of thyroid pathologies, ranging from benign multinodular goiters and toxic adenomas to localized and advanced thyroid malignancies. Since Theodor Kocher’s pioneering work in the late 19th century which reduced thyroid surgery mortality from over 50% to under 1% the safety profile of thyroidectomy has undergone exponential refinement. Modern surgical innovation, enhanced anatomical knowledge, and the widespread adoption of meticulous capsular dissection techniques have transformed thyroidectomy into a standardized procedure with negligible mortality. [1,2]

Despite these advancements, thyroid surgery continues to carry an inherent risk of early post-operative morbidity due to the dense anatomical architecture of the central neck compartment. The thyroid gland is intimately associated with vital neurovascular structures, specifically the recurrent laryngeal nerves (RLN), the external branches of the superior laryngeal nerve (EBSLN), and the parathyroid glands along with their delicate microvascular supply. [2,3]

Early post-operative complications defined as adverse events occurring within 30 days of surgery exert a significant impact on clinical recovery, length of hospital stay, and overall healthcare costs. The primary early complications of concern include:

1. Post-Operative Hypocalcemia: Resulting from mechanical trauma, devascularization, or inadvertent excision of the parathyroid glands (hypoparathyroidism). [4]
2. Recurrent Laryngeal Nerve Palsy: Manifesting as dysphonia, vocal fatigue, or life-threatening airway obstruction in cases of bilateral nerve injury. [5]
3. Post-Operative Neck Hematoma: A rapid, life-threatening emergency capable of causing fatal airway compromise through compressive tissue edema and laryngopharyngeal venous congestion. [6]
4. Wound Complications: Including seroma formation, superficial wound infection, and surgical site breakdown. [7]

While permanent complications (lasting >6 months) are relatively rare in high-volume centers (<2%), transient post-operative complications remain exceedingly common, with reported rates of transient hypocalcemia ranging from 10% to over 50% across global literature. Identifying patient, disease and procedure-related risk factors for these early adverse events is critical for establishing targeted preventive strategies, optimizing discharge protocols, and enhancing outpatient monitoring. [4-7]

Therefore, this prospective observational study was designed to systematically evaluate early surgical outcomes, quantify the incidence of early post-operative complications, and determine independent clinical predictors of morbidity in a consecutive series of adult patients undergoing thyroidectomy at a tertiary academic medical center.

Study Design and Ethical Clearance This prospective observational study was conducted within the Department of Otorhinolaryngology, ‘Maheshwara Medical College and Hospital’, in collaboration with Department of General Surgery, KBNU-Faculty of Medical Sciences; over a 6-month period. Institutional Ethics Committee clearance was obtained from both the institutions prior to study initiation. All clinical protocols adhered to the ethical principles governing human medical research as outlined in the Declaration of Helsinki. Informed written consent was obtained from all participating patients prior to enrollment. Sample Size Determination The sample size was calculated based on the reported international incidence of transient post-thyroidectomy hypocalcemia (approximately 20–25%). Utilizing a standard single-proportion formula for observational studies: n=(Z^2 X P X (1-P))/d^2 Where Z = 1.96 for a 95% confidence interval, P = 0.22 (estimated proportion of transient hypocalcemia), and d = 0.07 (absolute precision/margin of error). The minimum required sample size was calculated as n = 135. To account for potential dropouts, incomplete follow-up, or missing biochemical data, a total cohort of 150 consecutive patients was enrolled. Selection Criteria Inclusion Criteria: Adult patients aged 18 to 70 years. Patients scheduled for elective thyroid surgery (total thyroidectomy, subtotal/near-total thyroidectomy, or hemithyroidectomy/lobectomy). Patients providing written informed consent and agreeing to adhere to the 30-day post-operative follow-up protocol. Exclusion Criteria: Patients undergoing revision or re-operative thyroidectomy (due to altered anatomical planes confounding standard complication baseline rates). Pre-existing vocal cord paresis or paralysis documented on pre-operative laryngoscopy. Pre-existing chronic hypocalcemia, hyperparathyroidism, or underlying chronic kidney disease. Concurrent radical or modified radical lateral neck dissections for advanced metastatic disease (central neck dissection Level VI was permitted). Incomplete clinical or biochemical documentation. Surgical Protocol and Technique All procedures were performed under general endotracheal anesthesia using a standard low transverse collar (Kocher’s) incision. Surgical approach was standardized using the capsular dissection technique: The thyroid gland was reflected medially, and the tertiary branches of the superior and inferior thyroid arteries were ligated directly on the true capsule of the gland to preserve the blood supply to the upper and lower parathyroid glands. The recurrent laryngeal nerve (RLN) was routinely searched for, identified visually in the tracheoesophageal groove, exposed along its cervical course, and skeletonized up to its entry point into the larynx beneath the inferior constrictor muscle at the ligament of Berry. Parathyroid glands were systematically identified in situ. If a parathyroid gland was inadvertently devascularized or excised, it was immediately sectioned into 1mm3 fragments and auto-transplanted into individual pockets within the ipsilateral sternocleidomastoid muscle. Drain usage (closed suction active drain) was tailored to surgeon discretion based on intraoperative dead space and hemostatic confidence. Drains were routinely removed on post-operative day 1 or 2 when 24-hour output fell below 20 mL. Clinical Assessments and Outcome Parameters All participants underwent rigorous pre-operative, intra-operative, and post-operative monitoring. Pre-Operative Baseline: Comprehensive clinical history and physical examination. Serum biochemical panel: Corrected total serum calcium, ionic calcium, inorganic phosphate, serum albumin, renal function parameters, and intact parathyroid hormone (iPTH). Baseline indirect laryngoscopy or flexible fiberoptic nasopharyngolaryngoscopy to document bilateral vocal cord mobility. Post-Operative Monitoring Protocols: [9] Serum Calcium and iPTH: Measured at 24 hours and 48 hours post-operatively. Transient hypocalcemia was defined as a corrected total serum calcium level < 8.0mg/dL (<2.0mmol/L) or ionic calcium <1.15mmol/L, or the emergence of neuromuscular symptoms (paresthesias, Chvostek's sign, Trousseau's sign) requiring oral or IV calcium supplementation within 30 days. Permanent hypocalcemia was defined as persistent hypocalcemia requiring calcium and active vitamin D (calcitriol) replacement beyond 6 months. Vocal Cord Assessment: All patients underwent routine post-operative flexible fiberoptic laryngoscopy on post-operative day 1, and again at 2 weeks and 30 days. Any degree of restricted cord mobility or immobility was defined as RLN paresis/palsy. Recovery within 6 months was classified as transient, whereas persistence beyond 6 months was designated as permanent. Hemorrhage/Hematoma: Post-operative neck hematoma was classified as a major early complication if it caused clinical airway embarrassment or required emergency surgical re-exploration for evacuation. Wound Complications: Surgical site infections (SSIs) were defined using CDC criteria. Seromas were defined as fluid accumulations in the thyroid bed requiring needle aspiration. [9] Statistical Analysis Data were tabulated and processed using IBM SPSS Statistics version 28.0. Continuous variables were tested for normality using the Shapiro-Wilk test and presented as mean ± standard deviation (SD) or median with interquartile range (IQR). Categorical variables were expressed as absolute numbers and percentages (n%). Group comparisons for continuous variables were conducted using the independent Student's t-test or Mann-Whitney U test. Categorical variables were compared using the Chi-square (χ2) test or Fisher’s exact test where cell frequencies were < 5. Binary logistic regression analysis was executed to identify independent predictors of transient hypocalcemia; variables demonstrating a p < 0.10 in univariate analysis were entered into the multivariable model. Odds ratios (OR) with 95% confidence intervals (CI) were derived. Statistical significance was established at a two-tailed p < 0.05.

Patient Demographics and Baseline Clinical Characteristics

A total of 150 consecutive patients meeting all eligibility criteria completed the prospective observational protocol. The cohort exhibited a female-to-male ratio of 4.36:1, comprising 122 females (81.3%) and 28 males (18.7%). The mean age of the overall population was 42.6±11.4 years (range: 19 to 68 years).

Benign etiology was documented in 68.0% (n=102) of patients, dominated by multinodular goiter (54.0%), whereas malignant pathologies were identified in 32.0% (n=48) of cases, with papillary thyroid carcinoma (PTC) representing the vast majority (28.0%).

Table 1: Baseline Demographic and Clinical Profiles (N = 150)

Surgical Procedures and Operative Parameters

Total thyroidectomy was the primary surgical procedure performed, accounting for 62.0% (n=93) of all operations. Subtotal/near-total thyroidectomy was executed in 16.0% (n=24) of cases, and hemithyroidectomy/lobectomy was performed in 22.0% (n=33). Concomitant central neck dissection (Level VI) was carried out in 26.0% (n=39) of patients, predominantly those with confirmed or highly suspected malignant disease.

Visual identification of the RLN was successfully achieved in 98.3% (n = 239) of total nerves at risk (N = 243 nerves at risk across 150 patients). A total of 18 parathyroid glands across 15 patients were inadvertently devascularized or excised and underwent auto-transplantation into the sternocleidomastoid muscle.

Table 2: Surgical Distribution and Operative Metrics

Incidence of Early Post-Operative Complications

A total of 42 patients experienced one or more early post-operative complications, yielding an overall early morbidity rate of 28.0%. There were zero mortality cases recorded during the 30-day observational window.

1. Post-Operative Hypocalcemia: Transient biochemical or symptomatic hypocalcemia was the most common early complication, developing in 24.0% (n = 36) of the total population. Symptoms (perioral numbness, digital paresthesia) were observed in 14 of these 36 patients. All patients with transient hypocalcemia were successfully managed with oral calcium carbonate (1.5–3.0g/day) and oral calcitriol (0.25–0.5mcg/day). At the 6-month follow-up, hypocalcemia had resolved in 34 patients; permanent hypocalcemia persisted in 2 patients (1.33% of total cohort; 2.15% of total thyroidectomy cohort).
2. Recurrent Laryngeal Nerve Dysfunction: Early post-operative laryngoscopy identified transient RLN paresis in 6 nerves, representing a per-nerve-at-risk incidence of 2.47% (6/243) and a per-patient incidence of 4.0% (6/150). Patients presented with mild hoarseness or breathy dysphonia. Vocal cord function fully recovered within 8 to 16 weeks in 5 patients. One patient exhibited persistent vocal cord immobility at 6 months, establishing a permanent RLN palsy rate of 0.41% per nerve at risk (0.67% per patient).
3. Post-Operative Hematoma: Expanding compressive neck hematoma occurred in 3 patients (2.0%), all within the initial 8 hours post-operatively. These patients presented with rapid neck swelling, drain failure, and progressive stridor. Emergency bedside wound decompression followed by formal surgical re-exploration and hemostasis was executed successfully in all 3 cases without neurological or hypoxic sequelae.
4. Wound Complications: Superficial surgical site infection was noted in 2 patients (1.3%), resolving with wound care and oral antibiotics. Seroma formation occurred in 3 patients (2.0%), managed successfully via single bedside fine-needle aspiration.

Table 3: Profile of Early Post-Operative Complications

*Percentages calculated per patient cohort ( N = 150 ). Per-nerve-at-risk rates (N=243): Transient RLN=2.47%, Permanent RLN=0.41%.

Risk Factor Analysis for Transient Hypocalcemia

Given that transient hypocalcemia comprised the vast majority of early complications, univariate and multivariable logistic regression analyses were performed to identify predisposing clinical and surgical predictors (Table 4).

Univariate analysis revealed that total thyroidectomy (p=0.001), concomitant central neck dissection (p<0.001), malignant histopathology (p=0.008), and intraoperative parathyroid auto-transplantation (p=0.015) were significantly associated with an elevated risk of transient hypocalcemia. Age, gender, and gland weight did not demonstrate statistically significant associations.

In the multivariable logistic regression model, total thyroidectomy (OR = 3.82, 95% CI: 1.54–9.48,  p=0.004) and concomitant central neck dissection (OR = 4.12, 95% CI: 1.68–10.12,  p=0.002 ) retained independent statistical significance as key predictors of early transient hypocalcemia.

Table 4: Predictors of Transient Post-Thyroidectomy Hypocalcemia

(Multivariable Model)

*Indicates statistical significance ( p < 0.05 ).

Prospective clinical audits of surgical outcomes are essential for benchmarking quality of care, refining operative techniques, and personalizing post-operative management algorithms. This prospective observational study provides a detailed analysis of early outcomes following thyroidectomy in a cohort of 150 consecutive patients. Our findings confirm that while thyroidectomy is a remarkably safe procedure with a permanent complication rate under 2%, early transient morbidity specifically hypocalcemia remains relatively frequent, affecting nearly a quarter of all surgical candidates.

Post-Operative Hypocalcemia: Pathophysiology and Predictors

Hypocalcemia is universally recognized as the most frequent early adverse event following thyroid surgery. In our cohort, transient hypocalcemia occurred in 24.0% of patients, a rate that aligns closely with major international benchmarks such as the British Association of Endocrine and Thyroid Surgeons (BAETS) national audit (reporting rates between 20% and 30%) and the EUROCRINE database.[9-11]

The primary physiological driver of post-thyroidectomy hypocalcemia is transient hypoparathyroidism, caused by mechanical disturbance, thermal injury from energy devices, microvascular thrombosis, or acute ischemia of the parathyroid glands. The vascular supply to the parathyroids derived principally from delicate terminal branches of the inferior thyroid artery is exceptionally vulnerable during mobilization of the thyroid lobes. [12]

In our multivariable regression analysis, total thyroidectomy and concomitant central neck dissection (CND) emerged as powerful independent predictors of transient hypocalcemia, increasing the risk by 3.8 fold and 4.1-fold, respectively. The execution of a total thyroidectomy intrinsically exposes all four parathyroid glands to surgical risk, whereas hemithyroidectomy preserves the contralateral parathyroid complex intact, rendering systemic hypocalcemia virtually non-existent in unilateral procedures. Furthermore, performance of Level VI CND necessitates systematic clearance of fatty and lymphatic tissue surrounding the recurrent laryngeal nerves and anterior trachea, frequently compromising the lower parathyroid glands or their inferior vascular pedicles. [13]

The permanent hypocalcemia rate of 1.33% in our study reflects favorable surgical preservation techniques. Capsular dissection wherein dissection is restricted strictly to the true thyroid capsule, ligating individual vascular branches distal to the parathyroid blood supply remains the gold standard for preserving parathyroid function. [14]

Recurrent Laryngeal Nerve Management

Vocal cord dysfunction resulting from RLN trauma is a devastating complication that severely impacts speech mechanics, swallowing safety, and airway patency. [15] Our study documented a transient RLN paresis rate of 2.47% per nerve at risk (4.0% per patient) and a permanent RLN palsy rate of 0.41% per nerve at risk (0.67% per patient). These figures compare favorably with broad meta-analyses reporting transient RLN palsy rates of 2.0–6.0% and permanent palsy rates of 0.5–1.5%. [16]

The absolute mainstay of RLN preservation is routine visual identification. Historically, arguments favored avoiding nerve exposure to prevent mechanical traction; however, landmark prospective trials over the past three decades have conclusively established that visual identification and skeletonization of the nerve along its cervical trajectory significantly reduces injury rates compared to non-identification. [17] In our series, visual identification was achieved in 98.3% of nerves at risk.

The mechanism of transient paresis is predominantly neuropraxia, induced by blunt mechanical traction during lobe exteriorization, thermal dissipation from electrocautery or ultrasonic scalpels near the ligament of Berry, or localized post-operative edema. [18] The high rate of complete recovery observed in our trial (83.3% of paretic nerves recovered within 16 weeks) reinforces the concept that structural nerve continuity ensured by direct visual verification almost universally guarantees functional neural regeneration over time.

Post-Operative Neck Hematoma: Prevention and Emergency Protocols

Post-operative bleeding with expanding neck hematoma represents the most lethal early complication of thyroid surgery, capable of causing rapid, fatal respiratory arrest. The incidence of hematoma requiring re-exploration in our study was 2.0% (n=3), which is congruent with the established global range of 0.5% to 2.5%.

The anatomical mechanism of airway compromise from a neck hematoma is often misunderstood; it is rarely driven by direct tracheal compression alone. Rather, high-pressure arterial or venous bleeding beneath the rigid deep cervical fascia impairs venous and lymphatic drainage from the upper airway, resulting in massive, rapid mucosal edema of the supraglottic structures, arytenoids, and vocal folds.

In our cohort, all 3 hematomas presented within the first 8 hours post-operatively, underscoring that the immediate post-operative phase is the critical window for intensive airway monitoring. Essential elements to minimize hematoma risk include:

• Meticulous intraoperative hemostasis verified under Valsalva maneuvers prior to wound closure.
• Strict blood pressure control during emergence from anesthesia to prevent hyperdynamic spikes.
• Immediate bedside decompression (opening the skin incision, opening the strap muscles, and evacuating clot) at the first sign of respiratory distress or expanding neck mass, prior to transfer to the operating room for formal re-exploration.[19-20]

Clinical Implications and Discharge Protocols

The high incidence of transient hypocalcemia has historically driven prolonged hospital stays following total thyroidectomy. However, modern healthcare management heavily emphasizes safe early discharge (within 24 to 48 hours).

Our findings support the implementation of standardized biochemical risk stratification algorithms. Measuring 24-hour post-operative serum calcium and early iPTH kinetics can effectively identify low-risk patients eligible for rapid discharge versus high-risk patients (especially those undergoing total thyroidectomy with CND) who require prophylactic oral calcium and calcitriol supplementation.

This prospective observational study demonstrates that thyroidectomy is a highly safe surgical procedure with exceptionally low rates of permanent morbidity (<1.5%). However, early transient complications dominated by transient hypocalcemia (24.0%) and transient RLN paresis (4.0%) remain relatively common. Total thyroidectomy and concomitant central neck dissection are major independent risk factors for the development of early hypocalcemia. Adherence to capsular dissection, routine visual identification of the recurrent laryngeal nerve, and meticulous preservation of parathyroid microvascularization are fundamental surgical tenets. Standardized post-operative monitoring of serum calcium, coupled with early targeted supplementation, enables safe clinical recovery and minimizes early post-surgical morbidity.

1. Kocher T. Treatment of goiter. Lancet. 1883;122(3133):111-112.
2. Thomusch O, Machens A, Sekulla C, et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: Prospective multicenter study in 7,582 patients. World J Surg. 2000;24(11):1335-1341.
3. Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcemia. Br J Surg. 2014;101(4):307-320.
4. Sakr MF. Post-thyroidectomy hypocalcemia: incidence and risk factors. In: Parathyroid Gland Disorders: Controversies and Debates. Cham: Springer; 2022. p. 251-271.
5. De Crea C, Marincola G, D'Alatri L, Pennestrì F, Procopio PF, Gallucci P, et al. Laryngeal nerve palsy. In: Thyroid Surgery. Cham: Springer; 2023. p.145-154.
6. Manickavasagam J, Turner M, Ofo E, Kennedy M, Thiagarajan S, Fancy T. Management of emergencies and complications in head and neck practice. In: Stell & Maran's Head and Neck Surgery and Oncology. CRC Press; 2025. p.274-300.
7. Peng JM, Ansingkar KK, Landavazo BN, Shaikh AF, Rahimi M. A comprehensive review of seroma formation, prevention, and treatment approaches. Journal of Vascular Surgery Cases, Innovations and Techniques. 2025;11(5):101879.
8. Schafer AL, Shoback DM. Hypocalcemia: diagnosis and treatment. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
9. Noureldine SI, Seib CD, Buczek EJ, David M, Dhingra JK, Ganly I, James BC, Khoury N, Modi BP, Parangi S, Pitt SC. The American Thyroid Association multidisciplinary consensus statement on ambulatory thyroid surgery. Thyroid. 2026;36(6):561-81.
10. Barczyński M, Van Den Heede K, Lee JC, Lorenz K, Mihai R, Norlen O, Patel KN, Raffaelli M, Sippel RS, Wang TS, Solorzano CC. Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the International Association of Endocrine Surgeons. British Journal of Surgery. 2025;112(11):znaf247.
11. Staubitz JI, Poplawski A, Watzka F, Musholt TJ. Real-world EUROCRINE registry data challenge the reliability of Bethesda cytopathology for thyroid surgery indication. Innov Surg Sci. 2021;7(3-4):99-106.
12. Maheshwari M, Khan IA. Risk factors for transient and permanent hypoparathyroidism following thyroidectomy: a comprehensive review. Cureus. 2024;16(8):e66551.
13. Xu V, Renslo B, Cottrill EE. Central neck dissection: updates on indications and surgical technique. Operative Techniques in Otolaryngology-Head and Neck Surgery. 2024;35(4):331-7.
14. Rao SS, Rao H, Moinuddin Z, Rozario AP, Augustine T. Preservation of parathyroid glands during thyroid and neck surgery. Frontiers in endocrinology. 2023;14:1173950.
15. Kofopoulos-Lymperis E, Stavrati K, Papaconstantinou D, Pikoulis E, Peppa M, Chaidas K, Delides A, Nastos K. Beyond Surgical Injury: Systemic Etiologies of Recurrent Laryngeal Nerve Palsy. In Vivo. 2025;39(6):3090-105.
16. Mohamed AJ, Mohamedahmed R, Aboussaid M, Edrees RA, Alghawee MM, Ahmed A, ALGHAWEE MM, Ahmed Sr A. Iatrogenic Nerve Injuries in Head and Neck Surgeries: A Systematic Review of Mechanisms, Outcomes, and Prevention Strategies. Cureus. 2026 Jan 18;18(1):e101768.
17. Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT. Recurrent laryngeal nerve monitoring versus identification alone on post‚Äêthyroidectomy true vocal fold palsy: a meta‚Äêanalysis. The Laryngoscope. 2011 May;121(5):1009-17.
18. Carballo Cuello CM, De Jesus O.N. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.
19. Carcoforo P, Sibilla MG, Koleva Radica M. Cervical hematoma and wound complications. In: Thyroid Surgery. Cham: Springer; 2023. p.155-160.
20. Iliff HA, El‚ÄêBoghdadly K, Ahmad I, Davis J, Harris A, Khan S, Lan‚ÄêPak‚ÄêKee V, O'Connor J, Powell L, Rees G, Tatla TS. Management of haematoma after thyroid surgery: systematic review and multidisciplinary consensus guidelines from the Difficult Airway Society, the British Association of Endocrine and Thyroid Surgeons and the British Association of Otorhinolaryngology, Head and Neck Surgery. Anaesthesia. 2022 Jan;77(1):82-95.